An interventional study of EIT measurement and Staircase Recruitment Maneuvers with EIT guided and decremental PEEP trial in ARDS, Pediatric Respiratory Distress Syndrome and Respiratory Disease, sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Recruiting at 1 site in Italy. Open to participants aged 1 Month to 5 Years. Per ClinicalTrials.gov, last updated 2023-10-04.
Sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 91 studies in Respiratory Distress Syndrome with a site in Italy — 21 open to participants now, 24 under way, 2 of them phase 3. Respiratory Distress Syndrome · Italy.
Among the 91 studies in Respiratory Distress Syndrome with a site in Italy, this one is the 46th largest by planned enrollment of the 49 interventional ones that give a count, is one of 11 that started in 2022, is one of 31 with no phase, reaches primary completion later than 0 of the 23 other live ones, and was the 71st registered.
1,389 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.
Browse Respiratory Distress Syndrome studies →21 of the 91 studies in Respiratory Distress Syndrome with a site in Italy are open now. Recruiting first, the newest first:
Istituto Clinico Humanitas · Sites in Italy
Ages 18+
University of Padova · Sites in Italy
Ages 18+ · Healthy volunteers
University College Dublin · Sites in Italy, Croatia, Czechia and 6 more countries
Ages 0 min–28 days
University of Bologna · Sites in Italy
Ages 18–100
BioAegis Therapeutics Inc. · Sites in Italy, United States, Belgium and 10 more countries
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.
This study: 1 Month to 5 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
91 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 11 · Phase 3 11
First in 2002; this study’s year is marked. 11 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 13 is below the median of 60 across 823 interventional studies indexed under Respiratory Distress Syndrome.
Median enrollment 50 across the 49 interventional studies, 110 across the 39 observational. Of the 49 that completed or were terminated, 6 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 91 have an industry lead sponsor. The 10 most frequent:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico is the lead sponsor of 237 studies on the registry; 81 are open to participants now.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico has 9 studies filed under Respiratory Distress Syndrome — fewer than ten, so there is no comparison to draw.
11 of the studies in Respiratory Distress Syndrome with a site in Italy that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05624450Phase 3AstraZenecaEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | 2027-11-04 |
| NCT04460859Unity Health TorontoRecruitmEnt Assessed by eleCtRical Impedance Tomography | 2026-12 |
| NCT07402174Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoEIT- Guided Lung Recruitment in pARDS | 2026-12-01 |
| NCT07686315Istituto Clinico HumanitasAdvanced Respiratory Monitoring for Safer Mechanical Ventilation in Patients Without Respiratory Failure | 2026-12-30 |
| NCT04903262University of BolognaUltra-Protective Lung Ventilation With Extracorporeal CO2 Removal for Moderate ARDS | 2026-12-31 |
Add all 11 to your calendar (.ics) → With an account.
Among the 91 studies in Respiratory Distress Syndrome with a site in Italy, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
There is evidence from randomized controlled trials in adult patients with Acute Respiratory Distress Syndrome (ARDS) suggesting that delivering small tidal volumes with adequate levels of Positive End-Expiratory Pressure (PEEP) and a restrictive fluid strategy could improve outcome. However, there are data and common bedside experience that individual patients may or may not respond to interventions, such as escalation of PEEP or positional changes, and there may be a role for a more personalized ventilator strategy.
This strategy could account for the unique individual morphology of lung disease, such as the amount of atelectasis and overdistension as a percentage of total lung tissue, the exact location of atelectasis, and whether positional changes or elevation of PEEP produce lung recruitment or overdistension.
Stepwise Recruitment maneuvers (SRMs) in pARDS improve oxygenation in majority of patients. SRMs should be considered for use on an individualized basis in patients with pARDS should be considered if SpO2 decreases by ≥ 5% within 5 minutes of disconnection during suction or coughing or agitation. If a recruitment maneuver is conducted, a decremental PEEP trial must be done to determine the minimum PEEP that sustains the benefits of the recruitment maneuver.
Electrical impedance tomography (EIT), a bedside monitor to describe regional lung volume changes, displays a real-time cross-sectional image of the lung. EIT is a non-invasive, non-operator dependent, bedside, radiations-free diagnostic tool, feasible in paediatric patients and repeatable. It allows to study ventilation distribution dividing lungs in four Region Of Interest (ROI), that are layers distributed in an anteroposterior direction, and shows how ventilation is distributed in the areas concerned.
EIT measures and calculates other parameters that are related not only to the distribution of ventilation, but also to the homogeneity of ventilation and the response to certain therapeutic maneuvers, such as SRMs or PEEP-application.
Aim of this study is to provide a protocolized strategy to assess optimal recruitment and PEEP setting, tailored on the patients individual response in pARDS.
Inclusion Criteria:
Exclusion Criteria: Patients with one or more of the following characteristics:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
mechanical ventilation will be set according to the standard of care criteria
Device: EIT measurement
EIT guided mechanical ventilation will be set
Device: Staircase Recruitment Maneuvers with EIT guided and decremental PEEP trial · Device: Setting of EIT-guided mechanical ventilation
evaluation of mechanical ventilation after 24h EIT-guided ventilation
Device: Reevaluation after 24 h
Evaluation of mechanical ventilation and ventilation distribution through EIT. Mechanical ventilation is set by the physician according to clinical protocolized criteria
SRMs will be performed with a standardized ventilation protocol. Patient will be sedated, paralyzed and ventilated in pressure controlled mode, FIO2 to obtain SPO2\> 92%, RR 25, I:E =1:1.5. Alarm of pressure limit will be set at 35 cmH2O. The ventilator will be equipped with inspiratory and expiratory hold taste. Inspiratory and expiratory occlusion will be held for 5 seconds, data will be stored and analyzed with the ventilator own tool. Decremental PEEP trial will start if plateau pressure 30 cmH2O will be reached or end inspiratory transpulmonary pressure will exceed 28 cmH2O value. Once reached this level of plateau or transpulmonary pressure, PEEP will be reduced in three steps from 12, 10 and finally to 8 cmH2O every 20 minutes
Also known as: SRMs EIT-guided and DP trial
Mechanical ventilation is set according to EIT measurement
Evaluation of mechanical ventilation and ventilation distribution through EIT after 24h of ventilation EIT-guided
Regional Ventilation Delay, RDV (pixels %), at T2 and T0
RDV is an index of atelectrauma, supra-distention and in general an inhomogeneous ventilation
Time frame: 1 day
Differences in Tidal Impedance Distribution,TID (pixels %), at T0, T1 and T2
for every breathing cycle, a so-called tidal image is generated and each pixel of represents the difference in impedance between end-inspiration and end-expiration. The median value of each tidal image is calculated for the lung area
Time frame: 1 day
Gravity Centre, GC, differences (pixels %) at T0, T1 and T2
it is the weighted mean of row sums obtained from TV image and it indicates ventral-to-dorsal shifts in ventilation distribution due to lung opening and closing
Time frame: 1 day
Respiratory Rate at T0, T1 and T2
Respiratory rate (breaths/min)
Time frame: 1 day
FiO2 (%) at T0, T1 and T2
FiO2 (%)
Time frame: 1 day
Respiratory compliance at T0, T1 and T2
Respiratory System Compliance
Time frame: 1 day
Lung compliance at T0, T1 and T2
Clung Lung compliance
Time frame: 1 day
Chest Wall compliance at T0, T1 and T2
Chest Wall compliance
Time frame: 1 day
S/F ratio at T0, T1 and T2
S/F ratio
Time frame: 1 day
Sistolic Blood Pressure at T0, T1 and T2
SBP (mmHg)
Time frame: 1 day
Diastolic Blood Pressure at T0, T1 and T2
DBP (mmHg)
Time frame: 1 day
pH at T0, T1 and T2
pH
Time frame: 1 day
SpO2 at T0, T1 and T2
SpO2 (%)
Time frame: 1 day
PaO2 at T0, T1 and T2
PaO2 (mmHg)
Time frame: 1 day
Plan to share: No
Started Jan 2022 (actual). Primary completion is estimated for Dec 2023, 23 months after the start.
Of 266 non-industry interventional studies with no phase under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 23 months is close to that.
Counting every sponsor, half of 273 studies reached it within 24 months; a quarter within 12 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome →
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico →